In this week’s issue:
• UBC Faculty Research Awards – Internal Faculty of Medicine signature deadlines
• Department of Defense – Various Opportunities
• Simons Foundation Autism Research Initiative – Whole Genome Analysis for Autism Risk Variants
• Genome Canada – Disruptive Innovation in Genomics
• NSERC – PromoScience
• Genome Canada – Genomic Applications Partnership Program
• UBC Faculty of Medicine Continuing Professional Development Sexual Health Forum: Online Journal Club & Practice-Based Dialogue (reminder)
UBC Faculty Research Awards – Internal Faculty of Medicine Signature Deadlines
The Office of the Vice-President Research & International recently sent out a call for nominations for UBC Faculty Research Awards. The awards applicable to Faculty of Medicine researchers, and their internal signature deadlines are as follows:
• UBC Killam Faculty Research Fellowship – September 10, 2015
• UBC Killam Faculty Research Prize – September 28, 2015
• Charles A. McDowell Research Award – October 12, 2015
• Jacob Biely Research Prize – October 12, 2015
Please note that these are internal signature deadlines. If you require additional time to complete the application packages, please contact Bryan Wong (firstname.lastname@example.org) and he will be happy to accommodate your request.
Department of Defense – Various Opportunities
Pre-application Deadline: See below
The Department of Defense has recently released the following FY15 funding opportunities:
• Duchenne Muscular Dystrophy Research Program (DMDRP)
o Pre-Application Deadline: July 22, 2015
• Military Burn Research Program (MBRP)
o Pre-Application Deadline: August 20, 2015
• Peer Reviewed Cancer Research Program (PRCRP)
o Pre-Application Deadline: August 11, 2015
• Peer Reviewed Orthopaedic Research Program (PRORP)
o Pre-Application Deadline: August 13, 2015
• Spinal Cord Injury Research Program (SCIRP)
o Pre-Application Deadline: July 13, 2015
All pre-applications are required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline.
All applications must conform to the final Program Announcements and General Application Instructions that are available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov at http://grants.gov/.
Simons Foundation Autism Research Initiative – Whole Genome Analysis for Autism Risk Variants
Pre-application Deadline: July 28, 2015
Application Deadline: August 15, 2015
The Simons Foundation Autism Research Initiative (SFARI) has released the Whole-Genome Analysis for Autism Risk Variants request for applications (RFA).
Grants awarded through this RFA are intended to advance our understanding of the genetic basis of autism and, in particular, to begin to assess genetic variants conferring risk in non-coding regions and in coding regions of the genome that may be less accessible to whole-exome sequencing.
Maximum Funding: $250,000 (including indirect costs)
Grant Period: no more than 18 months
For further details, please visit the SFARI website.
Genome Canada – Disruptive Innovation in Genomics
Registration Deadline: September 4, 2015
Application Deadline: Contact Genome BC
The development of new disruptive technologies is fundamental to Genome Canada’s ability to deliver on the goals set out in its Strategic Plan and is tightly coupled to the provision of access to leading-edge technologies as it relates to genomics . Genome Canada believes that this can be achieved by supporting innovation from conception of an idea leading to transfer of knowledge and technologies from academia to users in ways that will maximize the impact of this initial investment and lead to economic and social benefits for Canada. The Disruptive Innovation in Genomics (DIG) initiative will ensure that true disruptive innovation is captured and transferred to those who have the ability to translate and use it. It is expected that this initiative will attract those who embrace strongly the notion of convergence of technologies from divergent fields.
The major objective of this RFA is to support the development of disruptive innovation in the field of genomics, which for the purpose of this RFA is defined as a new genomics-based technology or the application of an existing technology from another field, applied to the field of genomics, that is truly transformative in that it has the potential to either displace an existing technology, disrupt an existing market or create a new market. A disruptive innovation offers the capability to do things not previously possible and is not an incremental improvement of an existing technology.
To maximize the benefits for the genomics community, the DIG program will be delivered in two phases:
• Phase 1 will support activities to prove the feasibility of an “idea” – does this technology work and what can it do? This phase is intended to attract ideas for potential disruptive innovations from either individuals with a need (i.e., users), technology developers or others with great ideas.
• Phase 2 will support the development of a prototype (process, product and/or method) advancing the “idea”.
A total of $15 million is available from Genome Canada for Phases 1 and 2.
For further details, please visit the Genome Canada website.
NSERC – PromoScience
Deadline: September 15, 2015
NSERC’s PromoScience Program offers financial support for organizations working with young Canadians to promote an understanding of science and engineering (including mathematics and technology). Organizations may request funds for up to three years at a time.
PromoScience supports hands-on learning experiences for young students and their science teachers. Grants may be used to cover improvements to program content or delivery, as well as for new programs and activities. Grants can also be used to cover operational costs such as salaries, travel, postage, materials and supplies, provided that they relate to the promotion of science and engineering. Please note that grants may not be used to support research or program evaluations.
For further details, please visit the NSERC website.
Genome Canada – Genomic Applications Partnership Program
Deadline: September 25, 2015
The Genomic Applications Partnership Program (GAPP) represents a key element in Genome Canada’s strategic plan towards funding downstream research and development (R&D) projects that address real world challenges and opportunities as identified by industry, government, not-for-profits and other “Users” of genomics research.
Genome Canada is a catalyst for developing and applying genomics for the benefit of Canadians. Genome Canada builds bridges between government, academia and industry to forge a genomics-based public-private innovation enterprise focused on key life science sectors (human health, agriculture, fisheries, forestry, energy, mining, and environment). Genome Canada and the regional Genome Centres have made significant investments in large-scale genomics1 research and leading-edge technologies which has allowed Canada to become a leader in the field of genomics. We are now focusing a significant amount of effort to build and improve ways of translating discoveries into new applications by enabling the transfer of knowledge and technologies from Academia to the User community in ways that will maximize the impact of this initial investment and lead to economic and social benefits for Canada.
The GAPP aims to:
• promote the application of genomics-derived solutions to address key sector challenges or opportunities facing Users – User “pull”;
• promote commercialization of genomics technologies by enabling the transfer of genomics-derived solutions from Academia to Users as well as de-risking and incentivizing follow-on investment from public and private partners;
• increase the socio-economic impact of genomics research by accelerating its translation to application or market; and,
• create and foster a more productive interface between Academia and Users.
• Up to $30 million is available from Genome Canada for this program.
• Genome Canada will provide support for projects, ranging in size from $300,000 to $6 million in total project budget, with the Genome Canada investment not to exceed more than 1/3 of the total investment in the project by all parties. The remaining 2/3 must be secured through co-funding with at least 1/3 provided by the User(s) (see Section 9 and Appendix 2 of the GAPP Investment Strategy and Guidelines for more details on co-funding).
• Generally, the project term should be a minimum of six months to a maximum of three years. A shorter or longer term will be considered, but only if a strong rationale is provided.
For further information, please visit the Genome Canada website.
UBC Faculty of Medicine Continuing Professional Development Sexual Health Forum: Online Journal Club & Practice-Based Dialogue
Date: August 5, 2015 to June 19, 2016
Location: Online journal club and dialogue
Target audience: Family physicians
Up to 12.0 Mainpro-M1 credits
We are excited to launch this first ever sexual health online community of practice through UBC CPD. The Sexual Health Forum is a virtual community of practice – a place for physicians to learn from and with each other, and to expand knowledge, skills, and expertise in order to provide the best care for patients in the realm of sexual health care.
The Sexual Health Forum provides two main ways for you to engage with your colleagues:
1 – A Journal Club – made up of six five-week sessions starting on August 5, 2015 running to June 19, 2016 (up to 12.0 study credits).
2 – An ongoing practice-based Dialogue – where you are invited to discuss anything relevant to sexual health and clinical practice with other members of this online forum.
By participating in this community of practice you will:
• Recognize the importance of sexual health for the well-being of patients of all ages, genders, and orientations;
• Think critically about issues affecting sexual health and sexual health care delivery;
• Contribute to a learning community of primary care clinicians who are interested in sexual health; and
• Acquire knowledge, strategies, and skills to improve healthcare and health outcomes for patients.
Please contact email@example.com for more information.